DeltaQuest Foundation has a Board of Directors of experts in fields related to organizational governance. Our Board of Dirctors is comprised of: Carolyn E. Schwartz, Sc.D., Eric Amundsen, Ph.D., Alan Lisak, and Don Sackman.

Carolyn E. Schwartz, Sc.D., President and Chief Scientist. Dr. Carolyn E. Schwartz, earned a bachelor's degree Magna Cum Laude (1982) in Psychology from UCLA, a master's degree in Clinical Psychology (1985) at the University of Connecticut, and a Doctor of Science degree (Sc.D., 1990) from the Harvard School of Public Health with an emphasis on Behavioral Sciences, Biostatistics, and Immunology/Cancer Biology. She did her postdoctoral training in multiple sclerosis at the Center for Neurologic Diseases of the Brigham and Women's Hospital of Harvard Medical School. She founded and headed the Behavioral Science Research Program (1993-1999) at Frontier Science and Technology Research Foundation (a not-for-profit research foundation), and was a member of the Psychiatry faculty at Harvard Medical School (1995-1999). She served as Associate Professor and Associate Director of Research in the Department of Family Medicine and Community Health at the University of Massachusetts Medical School (1999-2002); and as Adjunct Professor (part-time) in the Faculty of Health Sciences, Department of Nursing at the Oslo and Akershus University College of Applied Sciences (April 2013 through March 2016). She has directed research programs in psychometrics, injury epidemiology, and spine research. She is currently President and Chief Scientist at DeltaQuest Foundation (1999 - present); and Adjunct Research Professor of Medicine and Orthopaedic Surgery (2008 – present) at the Tufts University School of Medicine, Boston, MA. Dr. Schwartz was the 2016 recipient of the International Society for Quality of Life Research President’s Award.

A specialist in outcomes research and measurement development, her interdisciplinary and methodological research focuses on understanding what patients can do to have an impact on the course of their disease and well-being. Her work has spanned a number of diseases and conditions, including cancer, aging, multiple sclerosis, rheumatoid arthritis, lupus, epilepsy, heart disease, diabetes, end-stage renal disease, depression, and spinal disorders. She has developed or assisted in the development of tools to measure a number of constructs, including assessment tools to measure impairment and disability, self-efficacy, illness distress, coping flexibility, quality of care, preference, sense of control, concept of a good death, health care providers' death anxiety, and quality of life at the end of life

Dr. Schwartz is the Co-Editor-in-Chief of Quality of Life Research. She was an Associate Editor for Quality of Life Research (2003-2007), and has also served as on the editorial board of Psychosomatic Medicine, the International Journal of Behavioral Medicine, and the Journal of Happiness Studies. She has recently served on several NIH grant review panels to review program project grants and small business innovative research grants. She is an ad hoc reviewer for numerous journals and international granting agencies. She is a Fellow of the Society of Behavioral Medicine, was a Fellow of the Consortium of Multiple Sclerosis Centers in 2009-2011, and has served on the Council of the American Psychosomatic Society, on the Board of Directors for the International Society for Quality of Life Research (ISOQOL), and on the Quality of Life Science Advisory Committee for the American Cancer Society. Her publications span the fields of behavioral medicine, health services research, neurology, oncology, physiatry, and orthopaedics

Eric L. Amundsen, J.D., Secretary of DeltaQuest Foundation, is a Senior Consultant at Geosyntec Consultants, Inc. in Acton, Massachusetts. Eric consults with organizations regarding energy transition issues as the world starts to reduce carbon intensity. Eric also performs Environmental, Social and Governance (ESG) due diligence and assists clients with analyzing environmental policy changes. He also works with clients to develop internal environmental policies and procedures. Prior to consulting, Eric was an intellectual property attorney and worked with a variety of clients with a focus on mechanical technologies. In a prior role, Eric worked as an environmental remediation engineer, a position in which he designed, installed, and operated soil and groundwater cleanup systems.

Alan M. Lisak, Treasurer of DeltaQuest Foundation, is currently the Chief Financial Officer at Middlesex Human Service Agency, Inc., in Waltham, MA. Alan earned his bachelor’s degree from Nichols College in 1984 and went on to lead an accounting staff at VMark Computer in Natick, MA and led them to an initial public offering. Alan then led an accounting team at another startup venture at Stardent Computer in Concord, MA. Following eight years in the high technology sector, Alan took on a controllership role at InfoGraphix, a Boston, MA based distributor of forms and promotional products. He then moved to Frontier Science & Technology Research Foundation, Inc. (FSTRF) in Boston, MA. (FSTRF), and oversaw its financial operations for over 15 years. FSTRF was a $50 million not-for-profit research foundation with a focus on conducting national and international cancer clinical trials.

Don Sackman, Conflict of Interest Officer of DeltaQuest Foundation, attended the Polytechnic Institute of Brooklyn earning a BS in Electrical Engineering. Upon graduation Don served as an active duty officer in the U.S. Army Corps of Engineers. After a 20 year corporate career in the computer business, first as a senior logic designer with the General Electric Computer Laboratory, and later as a Director of Licensing and Export for the international operations of Honeywell Information Systems, Mr. Sackman set out on his own in 1976, and subsequently founded three technology companies. His first and ongoing business, Sackman Associates, specializes in international technology transfer. Shortly after President Nixon and his Chinese counterparts reached an understanding that would open China to significant trade with the United States, Don founded STI - Systems Technology International - dedicated exclusively to high tech trade with the People’s Republic of China (PRC). A number of years later, Mr. Sackman founded Vertimag Systems Corporation, a venture capital financed international operation pioneering the development of extremely high-density "perpendicular magnetic recording" the precursor technology for most of today’s extremely large capacity computer hard drives. Mr. Sackman has also served as a long-time technology and international trade consultant to various agencies of the U.S. Government. He served two terms (4 years) as Chairman of the joint government- industry Computer Systems Technical Advisory Committee (CSTAC) as established by the U.S. Department of Commerce. In this role he established combined activities with the semiconductor advisory body. He received a presidential appointment (serving as computer industry expert) in the Electronics Sector of the U.S. Government Office of the Special Trade Representative working for Ambassador Robert Schwarz Strauss during the contentious bilateral trade and tariff negotiations with Japan. At the conclusion of the successful trade negotiations, Mr. Sackman was invited to participate in the resultant Trade Bill signing ceremony at the White House. Mr. Sackman also served as a (classified) technology advisor and consultant to the U.S. Government including the Central Intelligence Agency and the Defense Department.

Scott Fisher, Director of DeltaQuest Foundation, joined Pleasant Bay as a Managing Director in 2013. He brings over twenty years of private equity, M&A, and corporate strategy experience to the firm, primarily in the healthcare and life sciences sectors but also in business services and technology. Scott has a successful track record of working with companies to drive equity value creation.

Prior to joining Pleasant Bay, Scott was a Partner and co-founder of Centerstone Partners, an independent sponsor private equity firm where he led all aspects of the firm’s investment activities. At Centerstone, Scott helped build and finance several healthcare and life sciences companies as a founder, investor, operator and advisor, including Amerigen Pharmaceuticals, Theorem Clinical Research, and Cuda Pharmaceuticals among others. He sourced and executed these proprietary investment opportunities, working in close partnership with other institutional investors. Scott has served on the Boards of and advised numerous private companies, and his experience spans both domestic and emerging markets.

Previously, Scott was the Director of Corporate Development at Fisher Scientific International, where he led mergers and acquisitions for Fisher’s healthcare and diagnostics businesses. Prior to Fisher Scientific, Scott worked at Bain & Company, focusing on growth strategies and private equity engagements. Scott began his career in private equity at First Union Capital Partners, where he executed middle-market leveraged buyout and growth equity investments.

Scott holds an MBA from Harvard Business School and a BA in Economics from Duke University. He is married with two young children and lives outside of Boston.